Ovid Amadi manages multiomics portfolios and leads life sciences research at ARK Invest. He previously invested in medical technology at RTW Investments and advised healthcare companies at Boston Consulting Group, including a secondment to the World Economic Forum.
Ovid Amadi manages multiomics portfolios and leads life sciences research at ARK Invest. He previously invested in medical technology at RTW Investments and advised healthcare companies at Boston Consulting Group, including a secondment to the World Economic Forum.
Career
Multiomics Portfolio Manager and Director of Research at ARK Invest until Present